Personalized Medicine

Papers
(The H4-Index of Personalized Medicine is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Expanded Carrier Screening in Flanders (Belgium): An Online Survey on the Perspectives of Nonpregnant Reproductive-Aged Women39
The Role of Metabolomics in Personalized Medicine for Diabetes34
Attitudes of Costa Rican Individuals Towards Donation of Personal Genetic Data for Research20
Pathology-Supported Genetic Testing Presents Opportunities for Improved Disability Outcomes in Multiple Sclerosis18
European survey: citizens' attitudes on personalized medicine, genetic testing and health data sharing – design and delivery15
Successful Management of Delayed-Onset Adenosine Deaminase Deficiency with Novel Mutation13
Gene detection of VDR BsmI locus and its approteins, genes and growthplication in rational drug use in patients with osteoporosis13
Pharmacogenomic Testing for Mental Health (Part I): Documenting Early Adopter Perceptions of Use for Eight Scenarios12
Preliminary Radiogenomic Study of Hepatitis B Virus-Related Hepatocellular Carcinoma: Associations between MRI Features and Mutations11
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety10
Clinician Perspectives on Communication and Implementation Challenges in Precision Oncology10
Avoiding “Toxic Knowledge”: the Importance of Framing Personalized Risk Information in Clinical Decision-Making10
0.063869953155518